Christy Sutherland

995 total citations
35 papers, 708 citations indexed

About

Christy Sutherland is a scholar working on Public Health, Environmental and Occupational Health, Epidemiology and General Health Professions. According to data from OpenAlex, Christy Sutherland has authored 35 papers receiving a total of 708 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Public Health, Environmental and Occupational Health, 17 papers in Epidemiology and 8 papers in General Health Professions. Recurrent topics in Christy Sutherland's work include Opioid Use Disorder Treatment (20 papers), HIV, Drug Use, Sexual Risk (12 papers) and Substance Abuse Treatment and Outcomes (8 papers). Christy Sutherland is often cited by papers focused on Opioid Use Disorder Treatment (20 papers), HIV, Drug Use, Sexual Risk (12 papers) and Substance Abuse Treatment and Outcomes (8 papers). Christy Sutherland collaborates with scholars based in Canada, United States and Australia. Christy Sutherland's co-authors include Thomas Kerr, Nadia Fairbairn, Andrew Ivsins, Jade Boyd, Ryan McNeil, Rupinder Brar, Samara Mayer, D. G. Rayns, C.E. Devine and P K Ngai and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and American Journal of Public Health.

In The Last Decade

Christy Sutherland

32 papers receiving 688 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christy Sutherland Canada 16 378 336 161 119 72 35 708
Paul J. Joudrey United States 15 563 1.5× 466 1.4× 108 0.7× 40 0.3× 29 0.4× 37 769
Micah Piske Canada 12 273 0.7× 213 0.6× 63 0.4× 121 1.0× 9 0.1× 30 526
Alex Wodak Australia 12 149 0.4× 372 1.1× 111 0.7× 39 0.3× 31 0.4× 19 687
Marjorie Black United Kingdom 12 167 0.4× 117 0.3× 38 0.2× 62 0.5× 62 0.9× 23 585
Anna Fugelstad Sweden 14 351 0.9× 335 1.0× 146 0.9× 21 0.2× 7 0.1× 25 713
Peter P. Mueller United States 8 340 0.9× 214 0.6× 47 0.3× 16 0.1× 12 0.2× 15 557
Albert Hasson United States 16 450 1.2× 524 1.6× 121 0.8× 24 0.2× 6 0.1× 27 881
Naoko Ronquest United States 11 287 0.8× 191 0.6× 38 0.2× 13 0.1× 14 0.2× 21 399
Karl E. Williams United States 11 171 0.5× 104 0.3× 37 0.2× 16 0.1× 45 0.6× 19 366
Susannah O’Brien Australia 8 482 1.3× 444 1.3× 46 0.3× 19 0.2× 7 0.1× 11 625

Countries citing papers authored by Christy Sutherland

Since Specialization
Citations

This map shows the geographic impact of Christy Sutherland's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christy Sutherland with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christy Sutherland more than expected).

Fields of papers citing papers by Christy Sutherland

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christy Sutherland. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christy Sutherland. The network helps show where Christy Sutherland may publish in the future.

Co-authorship network of co-authors of Christy Sutherland

This figure shows the co-authorship network connecting the top 25 collaborators of Christy Sutherland. A scholar is included among the top collaborators of Christy Sutherland based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christy Sutherland. Christy Sutherland is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Erro, Roberto, Tanya S. Hauck, Daniel Ciccarone, et al.. (2025). Frozen in Addiction: A New Wave of Drug‐Induced Movement Disorders?. Movement Disorders. 40(12). 2596–2603.
2.
Ivsins, Andrew, Christy Sutherland, Thomas Kerr, & Mary Clare Kennedy. (2025). A Qualitative Study of Early Experiences and Outcomes of a Fentanyl Powder Safer Supply Program in Vancouver, Canada. Drug and Alcohol Dependence. 267. 111501–111501. 1 indexed citations
3.
Ivsins, Andrew, et al.. (2024). A qualitative evaluation of a fentanyl patch safer supply program in Vancouver, Canada. International Journal of Drug Policy. 131. 104547–104547. 4 indexed citations
4.
Bailey, Aaron O., C. Belcher, Henry N. Williams, et al.. (2023). Translating the lived experience of illicit drinkers into program guidance for cannabis substitution: Experiences from the Canadian Managed Alcohol Program Study. International Journal of Drug Policy. 122. 104244–104244. 1 indexed citations
5.
Glegg, Stephanie, Karen McCrae, Gillian Kolla, et al.. (2022). “COVID just kind of opened a can of whoop-ass”: The rapid growth of safer supply prescribing during the pandemic documented through an environmental scan of addiction and harm reduction services in Canada. International Journal of Drug Policy. 106. 103742–103742. 50 indexed citations
6.
McCrae, Karen, Stephanie Glegg, Marie-Ève Goyer, et al.. (2022). The changing landscape of pharmaceutical alternatives to the unregulated drug supply during COVID-19. Harm Reduction Journal. 19(1). 77–77. 8 indexed citations
7.
Sutherland, Christy, et al.. (2022). Role of stimulant replacement therapy in treating stimulant use disorders. Canadian Family Physician. 68(2). 109–111. 1 indexed citations
8.
Klaire, Sukhpreet, Christy Sutherland, Thomas Kerr, & Mary Clare Kennedy. (2022). A low-barrier, flexible safe supply program to prevent deaths from overdose. Canadian Medical Association Journal. 194(19). E674–E676. 29 indexed citations
9.
Klaire, Sukhpreet, Christy Sutherland, Thomas Kerr, & Mary Clare Kennedy. (2022). Un programme d’approvisionnement sécuritaire, souple et peu restrictif pour prévenir les décès par surdose. Canadian Medical Association Journal. 194(31). E1098–E1100.
10.
Fairbairn, Nadia, et al.. (2021). Supervised Tablet Injectable Opioid Agonist Therapy (TiOAT): A Strategy to Address Safer Supply for Individuals With an Opioid Use Disorder?. Journal of Addiction Medicine. 16(3). 258–260. 4 indexed citations
11.
Pauly, Bernie, Clifton Chow, Ashley Wettlaufer, et al.. (2021). “If I knew I could get that every hour instead of alcohol, I would take the cannabis”: need and feasibility of cannabis substitution implementation in Canadian managed alcohol programs. Harm Reduction Journal. 18(1). 65–65. 11 indexed citations
12.
Glegg, Stephanie, Christy Sutherland, Michael Trew, et al.. (2021). Service delivery models for injectable opioid agonist treatment in Canada: 2 sequential environmental scans. CMAJ Open. 9(1). E115–E124. 19 indexed citations
13.
Sutherland, Christy, et al.. (2020). Use of a primary care and pharmacy-based model for the delivery of injectable opioid agonist treatment for severe opioid use disorder: a case report. Canadian Medical Association Journal. 192(5). E115–E117. 2 indexed citations
14.
Ivsins, Andrew, Jade Boyd, Samara Mayer, et al.. (2020). Barriers and facilitators to a novel low-barrier hydromorphone distribution program in Vancouver, Canada: a qualitative study. Drug and Alcohol Dependence. 216. 108202–108202. 55 indexed citations
15.
Bach, Paxton, et al.. (2020). Innovative strategies to support physical distancing among individuals with active addiction. The Lancet Psychiatry. 7(9). 731–733. 15 indexed citations
16.
Ivsins, Andrew, Jade Boyd, Samara Mayer, et al.. (2020). “It’s Helped Me a Lot, Just Like to Stay Alive”: a Qualitative Analysis of Outcomes of a Novel Hydromorphone Tablet Distribution Program in Vancouver, Canada. Journal of Urban Health. 98(1). 59–69. 58 indexed citations
17.
Fairbairn, Nadia, Michael Trew, Scott Macdonald, et al.. (2019). Injectable opioid agonist treatment for opioid use disorder: a national clinical guideline. Canadian Medical Association Journal. 191(38). E1049–E1056. 64 indexed citations
18.
Sutherland, Christy, et al.. (2017). Challenges of treatment of acutely ill patients enrolled in a managed alcohol program. Drug and Alcohol Review. 37(S1). S143–S144. 1 indexed citations
19.
Milloy, M‐J, Kanna Hayashi, Huiru Dong, et al.. (2015). Impact of unstable housing on all-cause mortality among persons who inject drugs. BMC Public Health. 15(1). 106–106. 47 indexed citations
20.
Galina, Z. Harry, et al.. (1983). ACTH1–39 but not naltrexone produces biphasic effects on locomotor activity. Peptides. 4(1). 117–120. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul J. Joudrey Breakdown of academic impact, for papers by Micah Piske Breakdown of academic impact, for papers by Alex Wodak Breakdown of academic impact, for papers by Marjorie Black Breakdown of academic impact, for papers by Anna Fugelstad Breakdown of academic impact, for papers by Peter P. Mueller Breakdown of academic impact, for papers by Albert Hasson Breakdown of academic impact, for papers by Naoko Ronquest Breakdown of academic impact, for papers by Karl E. Williams Breakdown of academic impact, for papers by Susannah O’Brien
Rankless by CCL
2026